Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective
نویسندگان
چکیده
The European Medicines Agency (EMA) revises its guideline on minimizing risk in first-in-human trials to reflect changing practice and in light of a recent tragic incident.
منابع مشابه
Analyzing the European Union citizenship through feminist perspectives
The European Union has aspired to create an “ever closer union” among its people since the articulation of the European Union citizenship has been an important instrument towards it. However, attempts at creating this “ever closer union” have focused on homogenizing European citizens as a single entity without taking into account the heterogeneous differentials among such citizens. Gender diffe...
متن کاملPerspective of Mutual Recognition;Challenges and Mechanisms for Implementing it in the Area of European :::::::::union::::::::: Criminal Law
Abstract: Creation of new criminal law in the European ::::::::union:::::::: has led to an approximation of the criminal law of member states to each other. Compliance with this obligation for EU member states is due to the provisions of the Treaty of Lisbon. Main approach of the Treaty of Lisbon is to resort to the option of harmonizing the criminal laws of the member states, which is a new ch...
متن کاملNew opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical application.
In Japan, although orphan drug legislation has been established in 1993 to encourage drug research and development (R&D) for intractable and rare diseases, nearly half of the orphan drugs in the Japanese market originated from the European Union (EU) or the United States of America (USA). Availability of orphan drugs for intractable and rare diseases is compounded by the "drug lag" phenomenon, ...
متن کاملAccident rates in Poland’s foodstuff industry from the perspective of occupational safety management in the European Union
The issue of accidents at work and accident prevention have a significant impact regarding safety, health protection and work environment management for the European Union. Work conditions need to be improved in Poland. Solving this collective issue caused by humanitarian as well as economic considerations is a primary mission in businesses. Creating more quality jobs is one of the main goals o...
متن کاملSimilarities and differences in the oncology drug approval process between FDA and European Union with emphasis on in vitro companion diagnostics.
Drug approval [U.S. Food and Drug Administration (FDA), or market authorization for the European Union's European Medicines Agency (EMA)] is the most significant regulatory milestone for any drug, as drugs can only be marketed after marketing approval by a health authority. This article focuses on the main regulatory aspects of the drug approval process in the European Union (EU) and the United...
متن کامل